Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study (Q36019512)

11 August 2017

title

Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study (English)

1 reference

11 August 2017

F J García Ruiz

1

1 reference

11 August 2017

A Marín Ibáñez

2

1 reference

11 August 2017

F Pérez-Jiménez

3

1 reference

11 August 2017

X Pintó

4

1 reference

11 August 2017

G Nocea

5

1 reference

11 August 2017

C Ahumada

6

1 reference

11 August 2017

E Alemao

7

1 reference

11 August 2017

D Yin

8

1 reference

11 August 2017

REALITY Study Group

9

1 reference

11 August 2017

publication date

1 January 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

22 Suppl 3

1 reference

11 August 2017

page(s)

1-12

1 reference

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00002

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00002

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00002

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00002

European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00002

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00002

[New data on secondary prevention of myocardial infarction in Spain. Results of the PREVESE II study].

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00002

Variations in cholesterol management practices of U.S. physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00002

Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00002

Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00002

Cardiovascular disease risk profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00002

Current perspectives on statins

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00002

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00002

Risk factor prevalence and drug treatment in coronary patients at hospital discharge. Results of a national multicenter registry (3C Program)

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00002

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00002

Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00002

Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease

21 January 2018

1 reference

12 December 2020

EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events

1 reference

12 December 2020

Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events

1 reference

12 December 2020

[Secondary prevention of ischemic heart disease in the Cuidad Real Province, Spain. Effectiveness of lipid-lowering therapy in primary health care]

1 reference

12 December 2020

The rule of 5 and the rule of 7 in lipid-lowering by statin drugs.

1 reference

12 December 2020

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

1 reference

12 December 2020

[Secondary prevention of myocardial infarction in Spain. The PREVERSE study]

1 reference

12 December 2020

Prevention secondary to ischemic cardiopathy at the lipid level in primary care in Aragon. PRECIAR study 1

1 reference

12 December 2020

International comparison of awareness and attitudes towards coronary risk factor reduction: the HELP study. Heart European Leaders Panel

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group

1 reference

12 December 2020

10.2165/00019053-200422003-00002

Identifiers

DOI

0 references

Dimensions Publication ID

1023903535

0 references

1 reference